{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:52:21Z","timestamp":1764784341079,"version":"3.37.3"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["317465","287490"],"award-info":[{"award-number":["317465","287490"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004348","name":"Stockholm County Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Innovative Medicine at Karolinska Institutet"},{"name":"Stiftelsen Stockholms Sjukhem"},{"DOI":"10.13039\/501100006129","name":"Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003125","name":"Suomen Kulttuurirahasto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008320","name":"Finnish Brain Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008320","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Research Council","award":["804371"],"award-info":[{"award-number":["804371"]}]},{"DOI":"10.13039\/501100004756","name":"Emil Aaltosen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Determination of \u03b2-amyloid (A\u03b2) positivity and likelihood of underlying Alzheimer\u2019s disease (AD) relies on dichotomous biomarker cut-off values. Individuals with mild cognitive impairment (MCI) and A\u03b2 within the normal range may still have a substantial risk of developing dementia, primarily of Alzheimer type. Their prognosis, as well as predictors of clinical progression, are not fully understood. The aim of this study was to explore the associations of cerebrospinal fluid (CSF) biomarkers (A\u03b242, total tau, phosphorylated tau) and other characteristics, including modifiable vascular factors, with the risk of progression to dementia among patients with MCI and normal CSF A\u03b242.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Three hundred eighteen memory clinic patients with CSF and clinical data, and at least 1-year follow-up, were included. Patients had normal CSF A\u03b242 levels based on clinical cut-offs. Cox proportional hazard models with age as time scale and adjusted for sex, education, and cognition (Mini-Mental State Examination) were used to investigate predictors of progression to dementia and Alzheimer-type dementia. Potential predictors included CSF biomarkers, cognitive performance (verbal learning and memory), apolipoprotein E (<jats:italic>APOE<\/jats:italic>) \u03b54 genotype, medial temporal lobe atrophy, family history of dementia, depressive symptoms, and vascular factors, including the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) risk score. Predictive performance of patient characteristics was further explored with Harrell C statistic.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Lower normal A\u03b242 and higher total tau and phosphorylated tau were associated with higher dementia risk, and the association was not driven by A\u03b242 values close to cut-off. Additional predictors included poorer cognition, <jats:italic>APOE<\/jats:italic> \u03b54 genotype, higher systolic blood pressure, and lower body mass index, but not the CAIDE dementia risk score. A\u03b242 individually and in combination with other CSF biomarkers improved the risk prediction compared to age and cognition alone. Medial temporal lobe atrophy or vascular factors did not increase the predictive performance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Possibility of underlying AD pathology and increased dementia risk should not be ruled out among MCI patients with CSF A\u03b242 within the normal range. While cut-offs may be useful in clinical practice to identify high-risk individuals, personalized risk prediction tools incorporating continuous biomarkers may be preferable among individuals with intermediate risk. The role of modifiable vascular factors could be explored in this context.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-019-0557-1","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T23:02:36Z","timestamp":1575586956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Progression to dementia in memory clinic patients with mild cognitive impairment and normal \u03b2-amyloid"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1456-7991","authenticated-orcid":false,"given":"Anna","family":"Rosenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesna","family":"Jelic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ran","family":"Hagman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nenad","family":"Bogdanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miia","family":"Kivipelto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,5]]},"reference":[{"issue":"3","key":"557_CR1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/joim.12190","volume":"275","author":"RC Petersen","year":"2014","unstructured":"Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L. Mild cognitive impairment: a concept in evolution. J Intern Med. 2014;275(3):214\u201328.","journal-title":"J Intern Med"},{"issue":"4","key":"557_CR2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1600-0447.2008.01326.x","volume":"119","author":"AJ Mitchell","year":"2009","unstructured":"Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand. 2009;119(4):252\u201365.","journal-title":"Acta Psychiatr Scand"},{"issue":"8","key":"557_CR3","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"B Dubois","year":"2007","unstructured":"Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6(8):734\u201346.","journal-title":"Lancet Neurol"},{"issue":"11","key":"557_CR4","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","volume":"9","author":"B Dubois","year":"2010","unstructured":"Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, et al. Revising the definition of Alzheimer\u2019s disease: a new lexicon. Lancet Neurol. 2010;9(11):1118\u201327.","journal-title":"Lancet Neurol"},{"issue":"6","key":"557_CR5","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614\u201329.","journal-title":"Lancet Neurol"},{"issue":"3","key":"557_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):270\u20139.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"557_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):280\u201392.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"557_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","volume":"7","author":"CR Jack","year":"2011","unstructured":"Jack CR, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):257\u201362.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"557_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"557_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack","year":"2010","unstructured":"Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol. 2010;9(1):119\u201328.","journal-title":"Lancet Neurol"},{"issue":"3","key":"557_CR11","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3233\/JAD-132561","volume":"41","author":"M Zwan","year":"2014","unstructured":"Zwan M, van Harten A, Ossenkoppele R, Bouwman F, Teunissen C, Adriaanse S, et al. Concordance between cerebrospinal fluid biomarkers and [11C] PIB PET in a memory clinic cohort. J Alzheimers Dis. 2014;41(3):801\u20137.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"557_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13195-016-0233-7","volume":"9","author":"D Bertens","year":"2017","unstructured":"Bertens D, Tijms BM, Scheltens P, Teunissen CE, Visser PJ. Unbiased estimates of cerebrospinal fluid beta-amyloid 1-42 cutoffs in a large memory clinic population. Alzheimers Res Ther. 2017;9(1):8.","journal-title":"Alzheimers Res Ther"},{"issue":"Pt 5","key":"557_CR13","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/brain\/awv029","volume":"138","author":"SJ Vos","year":"2015","unstructured":"Vos SJ, Verhey F, Frolich L, Kornhuber J, Wiltfang J, Maier W, et al. Prevalence and prognosis of Alzheimer\u2019s disease at the mild cognitive impairment stage. Brain. 2015;138(Pt 5):1327\u201338.","journal-title":"Brain"},{"issue":"5","key":"557_CR14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1212\/WNL.0000000000001209","volume":"84","author":"A Caroli","year":"2015","unstructured":"Caroli A, Prestia A, Galluzzi S, Ferrari C, van der Flier WM, Ossenkoppele R, et al. Mild cognitive impairment with suspected nonamyloid pathology (SNAP): prediction of progression. Neurology. 2015;84(5):508\u201315.","journal-title":"Neurology"},{"issue":"1","key":"557_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13195-016-0220-z","volume":"8","author":"P Alexopoulos","year":"2016","unstructured":"Alexopoulos P, Werle L, Roesler J, Thierjung N, Gleixner LS, Yakushev I, et al. Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer\u2019s disease. Alzheimers Res Ther. 2016;8(1):51.","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"557_CR16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ana.23931","volume":"74","author":"RC Petersen","year":"2013","unstructured":"Petersen RC, Aisen P, Boeve BF, Geda YE, Ivnik RJ, Knopman DS, et al. Mild cognitive impairment due to Alzheimer disease in the community. Ann Neurol. 2013;74(2):199\u2013208.","journal-title":"Ann Neurol"},{"issue":"11","key":"557_CR17","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1212\/WNL.0b013e3182872830","volume":"80","author":"A Prestia","year":"2013","unstructured":"Prestia A, Caroli A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, et al. Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease. Neurology. 2013;80(11):1048\u201356.","journal-title":"Neurology"},{"issue":"5","key":"557_CR18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/ana.24921","volume":"81","author":"BM Tijms","year":"2017","unstructured":"Tijms BM, Bertens D, Slot RE, Gouw AA, Teunissen CE, Scheltens P, et al. Low normal cerebrospinal fluid Abeta42 levels predict clinical progression in nondemented subjects. Ann Neurol. 2017;81(5):749\u201353.","journal-title":"Ann Neurol"},{"issue":"3","key":"557_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398.","journal-title":"J Psychiatr Res"},{"key":"557_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neurobiolaging.2016.03.007","volume":"42","author":"D Enache","year":"2016","unstructured":"Enache D, Solomon A, Cavallin L, Kareholt I, Kramberger MG, Aarsland D, et al. CAIDE Dementia Risk Score and biomarkers of neurodegeneration in memory clinic patients without dementia. Neurobiol Aging. 2016;42:124\u201331.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"557_CR21","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","volume":"256","author":"B Winblad","year":"2004","unstructured":"Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256(3):240\u20136.","journal-title":"J Intern Med"},{"key":"557_CR22","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychological Association","year":"1994","unstructured":"American Psychological Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: APA; 1994.","edition":"4"},{"issue":"7","key":"557_CR23","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology. 1984;34(7):939\u201344.","journal-title":"Neurology"},{"issue":"2","key":"557_CR24","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1212\/WNL.43.2.250","volume":"43","author":"GC Roman","year":"1993","unstructured":"Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43(2):250\u201360.","journal-title":"Neurology."},{"issue":"6","key":"557_CR25","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546\u201354.","journal-title":"Neurology"},{"issue":"12","key":"557_CR26","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, et al. Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord. 2007;22(12):1689\u2013707.","journal-title":"Mov Disord"},{"issue":"8","key":"557_CR27","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jalz.2016.12.015","volume":"13","author":"RLH Handels","year":"2017","unstructured":"Handels RLH, Vos SJB, Kramberger MG, Jelic V, Blennow K, van Buchem M, et al. Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers. Alzheimers Dement. 2017;13(8):903\u201312.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"557_CR28","doi-asserted-by":"publisher","first-page":"e0116538","DOI":"10.1371\/journal.pone.0116538","volume":"10","author":"D Religa","year":"2015","unstructured":"Religa D, Fereshtehnejad SM, Cermakova P, Edlund AK, Garcia-Ptacek S, Granqvist N, et al. SveDem, the Swedish Dementia Registry - a tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice. PLoS One. 2015;10(2):e0116538.","journal-title":"PLoS One"},{"issue":"1","key":"557_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000334644","volume":"2","author":"MG Kramberger","year":"2012","unstructured":"Kramberger MG, Jelic V, Kareholt I, Enache D, Eriksdotter Jonhagen M, Winblad B, et al. Cerebrospinal fluid Alzheimer markers in depressed elderly subjects with and without Alzheimer\u2019s disease. Dement Geriatr Cogn Dis Extra. 2012;2(1):48\u201356.","journal-title":"Dement Geriatr Cogn Dis Extra"},{"issue":"3","key":"557_CR30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1159\/000366270","volume":"4","author":"S Garcia-Ptacek","year":"2014","unstructured":"Garcia-Ptacek S, Cavallin L, Kareholt I, Kramberger MG, Winblad B, Jelic V, et al. Subjective cognitive impairment subjects in our clinical practice. Dement Geriatr Cogn Dis Extra. 2014;4(3):419\u201330.","journal-title":"Dement Geriatr Cogn Dis Extra"},{"issue":"3","key":"557_CR31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1159\/000493749","volume":"8","author":"A Miley-Akerstedt","year":"2018","unstructured":"Miley-Akerstedt A, Jelic V, Marklund K, Walles H, Akerstedt T, Hagman G, et al. Lifestyle factors are important contributors to subjective memory complaints among patients without objective memory impairment or positive neurochemical biomarkers for Alzheimer\u2019s disease. Dement Geriatr Cogn Dis Extra. 2018;8(3):439\u201352.","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"557_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neurobiolaging.2019.08.032","volume":"83","author":"N Toschi","year":"2019","unstructured":"Toschi N, Lista S, Baldacci F, Cavedo E, Zetterberg H, Blennow K, et al. Biomarker-guided clustering of Alzheimer\u2019s disease clinical syndromes. Neurobiol Aging. 2019;83:42\u201353.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"557_CR33","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1373\/clinchem.2017.281055","volume":"64","author":"BM Tijms","year":"2018","unstructured":"Tijms BM, Willemse EAJ, Zwan MD, Mulder SD, Visser PJ, van Berckel BNM, et al. Unbiased approach to counteract upward drift in cerebrospinal fluid amyloid-beta 1-42 analysis results. Clin Chem. 2018;64(3):576\u201385.","journal-title":"Clin Chem"},{"issue":"1","key":"557_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jalz.2017.06.2264","volume":"14","author":"SE Schindler","year":"2018","unstructured":"Schindler SE, Sutphen CL, Teunissen C, McCue LM, Morris JC, Holtzman DM, et al. Upward drift in cerebrospinal fluid amyloid beta 42 assay values for more than 10 years. Alzheimers Dement. 2018;14(1):62\u201370.","journal-title":"Alzheimers Dement"},{"issue":"10","key":"557_CR35","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","volume":"55","author":"P Scheltens","year":"1992","unstructured":"Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, et al. Atrophy of medial temporal lobes on MRI in \u201cprobable\u201d Alzheimer\u2019s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967\u201372.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"557_CR36","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/1097-4679(198405)40:3<785::AID-JCLP2270400325>3.0.CO;2-4","volume":"40","author":"SJ Rosenberg","year":"1984","unstructured":"Rosenberg SJ, Ryan JJ, Prifitera A. Rey Auditory-Verbal Learning Test performance of patients with and without memory impairment. J Clin Psychol. 1984;40(3):785\u20137.","journal-title":"J Clin Psychol"},{"issue":"3","key":"557_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0006-3223(88)90038-8","volume":"23","author":"GS Alexopoulos","year":"1988","unstructured":"Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell scale for depression in dementia. Biol Psychiatry. 1988;23(3):271\u201384.","journal-title":"Biol Psychiatry"},{"issue":"9","key":"557_CR38","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S1474-4422(06)70537-3","volume":"5","author":"M Kivipelto","year":"2006","unstructured":"Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 2006;5(9):735\u201341.","journal-title":"Lancet Neurol"},{"issue":"5","key":"557_CR39","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jalz.2013.05.1772","volume":"10","author":"LG Exalto","year":"2014","unstructured":"Exalto LG, Quesenberry CP, Barnes D, Kivipelto M, Biessels GJ, Whitmer RA. Midlife risk score for the prediction of dementia four decades later. Alzheimers Dement. 2014;10(5):562\u201370.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"557_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrneurol.2015.251","volume":"12","author":"CR Jack","year":"2016","unstructured":"Jack CR, Knopman DS, Chetelat G, Dickson D, Fagan AM, Frisoni GB, et al. Suspected non-Alzheimer disease pathophysiology--concept and controversy. Nat Rev Neurol. 2016;12(2):117\u201324.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"557_CR41","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/ana.24903","volume":"81","author":"EL Abner","year":"2017","unstructured":"Abner EL, Kryscio RJ, Schmitt FA, Fardo DW, Moga DC, Ighodaro ET, et al. Outcomes after diagnosis of mild cognitive impairment in a large autopsy series. Ann Neurol. 2017;81(4):549\u201359.","journal-title":"Ann Neurol"},{"issue":"6","key":"557_CR42","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142(6):1503\u201327.","journal-title":"Brain"},{"issue":"11","key":"557_CR43","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","volume":"11","author":"Y Stern","year":"2012","unstructured":"Stern Y. Cognitive reserve in ageing and Alzheimer\u2019s disease. Lancet Neurol. 2012;11(11):1006\u201312.","journal-title":"Lancet Neurol"},{"issue":"11","key":"557_CR44","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1093\/brain\/awq277","volume":"133","author":"CR Jack","year":"2010","unstructured":"Jack CR, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, et al. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer\u2019s disease. Brain. 2010;133(11):3336\u201348.","journal-title":"Brain"},{"issue":"7","key":"557_CR45","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1001\/jamaneurol.2017.0892","volume":"74","author":"ME Farrell","year":"2017","unstructured":"Farrell ME, Kennedy KM, Rodrigue KM, Wig G, Bischof GN, Rieck JR, et al. Association of longitudinal cognitive decline with amyloid burden in middle-aged and older adults: evidence for a dose-response relationship. JAMA Neurol. 2017;74(7):830\u20138.","journal-title":"JAMA Neurol"},{"issue":"19","key":"557_CR46","doi-asserted-by":"publisher","first-page":"e1809","DOI":"10.1212\/WNL.0000000000006469","volume":"91","author":"ME Farrell","year":"2018","unstructured":"Farrell ME, Chen X, Rundle MM, Chan MY, Wig GS, Park DC. Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults. Neurology. 2018;91(19):e1809\u201321.","journal-title":"Neurology"},{"issue":"17","key":"557_CR47","doi-asserted-by":"publisher","first-page":"e1452","DOI":"10.1212\/WNL.0000000000005354","volume":"90","author":"SM Landau","year":"2018","unstructured":"Landau SM, Horng A, Jagust WJ, Alzheimer\u2019s Disease Neuroimaging Initiative. Memory decline accompanies subthreshold amyloid accumulation. Neurology. 2018;90(17):e1452\u201360.","journal-title":"Neurology"},{"issue":"12","key":"557_CR48","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1212\/WNL.0b013e318288690c","volume":"80","author":"SJ Vos","year":"2013","unstructured":"Vos SJ, van Rossum IA, Verhey F, Knol DL, Soininen H, Wahlund LO, et al. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI. Neurology. 2013;80(12):1124\u201332.","journal-title":"Neurology"},{"issue":"10","key":"557_CR49","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1136\/jnnp.2010.231555","volume":"82","author":"LS Elias-Sonnenschein","year":"2011","unstructured":"Elias-Sonnenschein LS, Viechtbauer W, Ramakers IH, Verhey FR, Visser PJ. Predictive value of APOE-epsilon4 allele for progression from MCI to AD-type dementia: a meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82(10):1149\u201356.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"557_CR50","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1001\/jamaneurol.2017.2712","volume":"74","author":"IS van Maurik","year":"2017","unstructured":"van Maurik IS, Zwan MD, Tijms BM, Bouwman FH, Teunissen CE, Scheltens P, et al. Interpreting biomarker results in individual patients with mild cognitive impairment in the Alzheimer\u2019s biomarkers in daily practice (ABIDE) project. JAMA Neurol. 2017;74(12):1481\u201391.","journal-title":"JAMA Neurol"},{"issue":"11","key":"557_CR51","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/S1474-4422(19)30283-2","volume":"18","author":"IS van Maurik","year":"2019","unstructured":"van Maurik IS, Vos SJ, Bos I, Bouwman FH, Teunissen CE, Scheltens P, et al. Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study. Lancet Neurol. 2019;18(11):1034\u201344.","journal-title":"Lancet Neurol"},{"key":"557_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neurobiolaging.2017.03.034","volume":"56","author":"I Bos","year":"2017","unstructured":"Bos I, Vos SJ, Frolich L, Kornhuber J, Wiltfang J, Maier W, et al. The frequency and influence of dementia risk factors in prodromal Alzheimer\u2019s disease. Neurobiol Aging. 2017;56:33\u201340.","journal-title":"Neurobiol Aging"},{"issue":"10","key":"557_CR53","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","volume":"62","author":"M Kivipelto","year":"2005","unstructured":"Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005;62(10):1556\u201360.","journal-title":"Arch Neurol"},{"issue":"1","key":"557_CR54","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12877-018-0876-2","volume":"18","author":"N Legdeur","year":"2018","unstructured":"Legdeur N, Heymans MW, Comijs HC, Huisman M, Maier AB, Visser PJ. Age dependency of risk factors for cognitive decline. BMC Geriatr. 2018;18(1):187.","journal-title":"BMC Geriatr"},{"issue":"3","key":"557_CR55","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/joim.12178","volume":"275","author":"A Solomon","year":"2014","unstructured":"Solomon A, Mangialasche F, Richard E, Andrieu S, Bennett DA, Breteler M, et al. Advances in the prevention of Alzheimer\u2019s disease and dementia. J Intern Med. 2014;275(3):229\u201350.","journal-title":"J Intern Med"},{"issue":"10","key":"557_CR56","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1212\/01.wnl.0000256368.57375.b7","volume":"68","author":"A Solomon","year":"2007","unstructured":"Solomon A, Kareholt I, Ngandu T, Winblad B, Nissinen A, Tuomilehto J, et al. Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology. 2007;68(10):751\u20136.","journal-title":"Neurology"},{"issue":"24","key":"557_CR57","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1212\/WNL.0000000000004741","volume":"89","author":"ER McGrath","year":"2017","unstructured":"McGrath ER, Beiser AS, DeCarli C, Plourde KL, Vasan RS, Greenberg SM, et al. Blood pressure from mid- to late life and risk of incident dementia. Neurology. 2017;89(24):2447\u201354.","journal-title":"Neurology"},{"issue":"6","key":"557_CR58","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1212\/01.wnl.0000176061.33817.90","volume":"65","author":"AS Buchman","year":"2005","unstructured":"Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA. Change in body mass index and risk of incident Alzheimer disease. Neurology. 2005;65(6):892\u20137.","journal-title":"Neurology"},{"issue":"5","key":"557_CR59","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp-2014-310095","volume":"87","author":"JQ Li","year":"2016","unstructured":"Li JQ, Tan L, Wang HF, Tan MS, Tan L, Xu W, et al. Risk factors for predicting progression from mild cognitive impairment to Alzheimer\u2019s disease: a systematic review and meta-analysis of cohort studies. J Neurol Neurosurg Psychiatry. 2016;87(5):476\u201384.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"557_CR60","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1212\/WNL.0b013e3182477eed","volume":"78","author":"N Mattsson","year":"2012","unstructured":"Mattsson N, Rosen E, Hansson O, Andreasen N, Parnetti L, Jonsson M, et al. Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology. 2012;78(7):468\u201376.","journal-title":"Neurology"},{"key":"557_CR61","volume-title":"Predictors of cognitive decline in memory clinic patients","author":"C Andersson","year":"2007","unstructured":"Andersson C. Predictors of cognitive decline in memory clinic patients. Karolinska Institutet; 2007."}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-019-0557-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-019-0557-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-019-0557-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:42:48Z","timestamp":1607042568000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-019-0557-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["557"],"URL":"https:\/\/doi.org\/10.1186\/s13195-019-0557-1","relation":{},"ISSN":["1758-9193"],"issn-type":[{"type":"electronic","value":"1758-9193"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"23 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Regional Ethical Review Board in Stockholm, and written informed consent was obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}